Al Hammadi Holding Company announced the completion of all necessary contractual and regulatory procedures for the acquisition of a 40% stake in Wared Healthcare Company . This move represents the culmination of the company's efforts to strengthen its investment portfolio and expand its operations in the Kingdom's healthcare sector.
Deal details and timeline
In a statement, the company clarified that this announcement follows its previous publication on the Saudi Stock Exchange (Tadawul) website on December 3rd, regarding the signing of a share subscription agreement in Wareed Healthcare Company. Under this agreement, Al Hammadi acquired the allocated stake, coinciding with the signing of a partnership agreement aimed at regulating the relationship between shareholders and establishing the legal and administrative framework for the company's management in the coming phase, thus ensuring effective governance that aligns with the aspirations of both parties.
Regulatory approvals and the role of the Competition Authority
In a related development, Al Hammadi Company noted that it had received a "no reporting requirement" certificate from the General Authority for Competition . This step is a fundamental requirement for mergers and acquisitions in Saudi Arabia, as it confirms that the transaction does not raise concerns regarding economic concentration or monopoly, and that it complies with the Competition Law and its implementing regulations, thus paving the way for the smooth completion of the deal.
The context of growth in the Saudi healthcare sector
This acquisition takes on particular significance when viewed within the context of the Kingdom's overall economic landscape. The Saudi healthcare sector is undergoing radical transformations and rapid growth, supported by Vision 2030 , which aims to enhance private sector participation and improve the efficiency of healthcare services. Al Hammadi Holding is a key player in this sector, continuously seeking investment opportunities that contribute to diversifying its revenue streams and strengthening its market position.
The trend of major companies to acquire stakes in specialized companies such as "Wareed Health" reflects a strategy of integrating services and a move towards building strong health entities capable of meeting the growing demand for medical services and innovative health solutions in the local market.
Next steps and financial impact
Al-Hammadi stated that it is finalizing the procedures for amending the articles of incorporation of Wared Medical Company to officially register the new ownership with the relevant authorities. Regarding the financial impact, the company indicated that the financial implications of this transaction on the company's financial statements and operations will be determined after all procedures are completed. Investors are awaiting this information to ascertain the expected returns from this strategic partnership.
